Company Monitoring Page for Achillion

latest headlines for company on cafepharma

5 Drugs That Investors May Be Undervaluing
Motley Fool
Mon, 07/13/15 - 11:04 am
Tags:
Amicus Therapeutics, Galafold, Receptos, ozanimod, GS-5816, Gilead Sciences, ACH-3102, Achillion, Ophthotech, Fovista
Will the J&J Deal With Achillion Transform the Hep C Market?
WSJ Pharmalot
Thu, 05/21/15 - 09:50 am
Tags:
JNJ, hepatitis C, Achillion
Achillion partners with J&J to develop hep C drugs
Yahoo/Reuters
Tue, 05/19/15 - 06:23 pm
Tags:
Achillion, JNJ, R&D, hepatitis C
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
TheStreet.com
Tue, 05/19/15 - 09:50 am
Tags:
M&A, social media, twitter, Gilead Sciences, hepatitis C, Achillion
Achillion Pharmaceuticals reports first-quarter loss but tops expectations
Yahoo/AP
Thu, 05/7/15 - 10:55 am
Tags:
Achillion, earnings
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Tags:
Gilead Sciences, Harvoni, hepatitis C, AbbVie, Bristol-Myers Squibb, Merck, Achillion
Should Gilead Sciences, Inc. Be Worried By Achillion Pharmaceuticals?
Motley Fool
Wed, 04/1/15 - 08:45 am
Tags:
Gilead Sciences, Achillion, hepatitis C, Sovaldi, Harvoni
[video]2 Small Biotech Stocks Dreaming Big in Hepatitis C
Motley Fool
Mon, 02/16/15 - 10:15 am
Tags:
hepatitis C, Regulus, Achillion
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Seeking Alpha
Mon, 02/9/15 - 08:26 am
Tags:
Achillion, hepatitis C, ACH-3102, Gilead Sciences, Sovaldi
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
Tags:
biotech, Avanir, OvaScience, Agios, Bluebird Bio, Receptos, Prosensa, Pernix, Achillion, Amicus Therapeutics, CytoSorbents, PTC Therapeutics
Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results
TheStreet.com
Mon, 12/22/14 - 01:14 pm
Tags:
Achillion, ACH-3422, hepatitis C, M&A
Why Gilead Sciences and AbbVie Care About This Tiny Company
Motley Fool
Thu, 12/11/14 - 10:32 am
Tags:
AbbVie, Gilead Sciences, Achillion, hepatitis C
These 4 Biotech Stocks Have Been On Fire
Yahoo/Benzinga
Mon, 12/8/14 - 11:12 pm
Tags:
Agios Pharmaceuticals, Achillion, Amicus Therapeutics, Orexigen
2 Skyrocketing Biotech Stocks In A Stalling Market
Yahoo/Benzinga
Mon, 11/17/14 - 04:40 pm
Tags:
Orexigen, Achillion
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
Tags:
hepatitis C, AbbVie, Achillion, Gilead Sciences, Merck
Achillion Pharmaceuticals (ACHN): A Potential Acquisition Target For Gilead Sciences (GILD)
Bidness Etc.
Tue, 11/11/14 - 10:32 am
Tags:
Achillion, M&A, Gilead Sciences, hepatitis C
Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Yahoo/AP
Mon, 11/10/14 - 03:55 pm
Tags:
Achillion, ACH-3102, hepatitis C, Sovaldi
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)
Yahoo/Globe NewsWire
Sat, 11/8/14 - 10:39 am
Tags:
Achillion, ACH-3102, ACH-3422, HCV, hepatitis C
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
Tags:
liver disease, Gilead Sciences, Intercept Pharma, Genfit, Merck, Achillion, AbbVie, NASH, hepatitis B, hepatitis C
Gilead Sciences: Here Comes the Competition
Barron's
Tue, 10/7/14 - 01:21 pm
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Merck, AbbVie, Idenix, Bristol-Myers Squibb, Achillion

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.